| Kalidas G Sahetya, MD | |
|
427 Us 31w Byp, Bowling Green, KY 42101-1703 | |
| (270) 796-8800 | |
| (270) 796-9328 |
| Full Name | Kalidas G Sahetya |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 50 Years |
| Location | 427 Us 31w Byp, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649258088 | NPI | - | NPPES |
| 000000050059 | Other | KY | ANTHEM BCBS |
| 64209802 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 20980 (Kentucky) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 20980 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Medical Center (bowling Green) | Bowling green, KY | Hospital |
| Greenview Regional Hospital | Bowling green, KY | Hospital |
| Caverna Memorial Hospital | Horse cave, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| K G Sahetya Psc | 0648205427 | 3 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
Proposition 63, which voters approved in 2004, was touted as a way to address serious mental illnesses in California, but in the years since, critics - including some of the original supporters - have argued that it has gone off the rails in its implementation.
This week, researchers report evidence that a statin drug already shown to be safe for use in humans has proven effective at correcting cell-cell communication and curing learning disfunction in a mouse model of Neurofibromatosis type I, a human genetic disorder that causes learning disabilities in millions of people worldwide.
Linden LLC, a Chicago-based healthcare focused private equity firm, today announced that it has successfully completed fundraising for Linden Capital Partners II, which closed with $375 million of committed capital and exceeded its target of $300 million and initial cap of $350 million.
› Verified 6 days ago
| Entity Name | K G Sahetya Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508805870 PECOS PAC ID: 0648205427 Enrollment ID: O20050929000999 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
Proposition 63, which voters approved in 2004, was touted as a way to address serious mental illnesses in California, but in the years since, critics - including some of the original supporters - have argued that it has gone off the rails in its implementation.
This week, researchers report evidence that a statin drug already shown to be safe for use in humans has proven effective at correcting cell-cell communication and curing learning disfunction in a mouse model of Neurofibromatosis type I, a human genetic disorder that causes learning disabilities in millions of people worldwide.
Linden LLC, a Chicago-based healthcare focused private equity firm, today announced that it has successfully completed fundraising for Linden Capital Partners II, which closed with $375 million of committed capital and exceeded its target of $300 million and initial cap of $350 million.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kalidas G Sahetya, MD Po Box 90039, Bowling Green, KY 42102-9039 Ph: (270) 796-8800 | Kalidas G Sahetya, MD 427 Us 31w Byp, Bowling Green, KY 42101-1703 Ph: (270) 796-8800 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
Proposition 63, which voters approved in 2004, was touted as a way to address serious mental illnesses in California, but in the years since, critics - including some of the original supporters - have argued that it has gone off the rails in its implementation.
This week, researchers report evidence that a statin drug already shown to be safe for use in humans has proven effective at correcting cell-cell communication and curing learning disfunction in a mouse model of Neurofibromatosis type I, a human genetic disorder that causes learning disabilities in millions of people worldwide.
Linden LLC, a Chicago-based healthcare focused private equity firm, today announced that it has successfully completed fundraising for Linden Capital Partners II, which closed with $375 million of committed capital and exceeded its target of $300 million and initial cap of $350 million.
› Verified 6 days ago
Rodney T. Steff, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 421 Us 31w Byp, Bowling Green, KY 42101 Phone: 270-782-0151 | |
Dr. Daniel R Long, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Park St, Bowling Green, KY 42101 Phone: 270-745-1000 | |
Dr. Rance Wentworth, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Park St, Bowling Green, KY 42101 Phone: 270-781-5111 Fax: 270-780-0462 | |
Pinky Dalal Gaba, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 427 Us 31w Byp, Bowling Green, KY 42101 Phone: 270-796-8800 Fax: 270-796-9328 | |
Ms. Uma Akkineni, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 250 Park St, Bowling Green, KY 42101 Phone: 270-796-6540 Fax: 270-796-6576 | |
Mohammed Kazimuddin, MD FACC FSCAI Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Second Ave, Ste B1, Bowling Green, KY 42101 Phone: 270-782-0151 Fax: 270-782-7528 | |
Ann Scarlet Monardo, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 484 Golden Autumn Way Ste 201, Bowling Green, KY 42103 Phone: 270-393-2759 |